Issued on behalf of Aleen Inc.
VANCOUVER – Equity Insider News Commentary – Healthcare organizations are adopting artificial intelligence solutions at 2.2 times the rate of the broader economy, with 22% now implementing domain-specific AI tools in 2025[1], while the global digital wellness sector simultaneously expands from $12.87 billion in 2025 toward a projected $45.65 billion by 2034[2]. Several publicly traded companies operating at the intersection of healthcare technology, enterprise software, and AI-powered wellness solutions are positioned to capture market share from this transformation, including Aleen Inc. (CSE: ALEN-U), Workday, Inc. (NASDAQ: WDAY), GE HealthCare Technologies (NASDAQ: GEHC), Johnson & Johnson (NYSE: JNJ), and NVIDIA Corporation (NASDAQ: NVDA).
Healthcare AI spending reached $1.4 billion in 2025, nearly tripling from the previous year, as health systems lead adoption at 27% implementation rates[3]. Patient engagement platforms are expanding at compound annual growth rates between 13% and 17%, creating favorable conditions for companies developing AI-powered wellness analytics, clinical workflow automation, and personalized health management solutions that address the massive administrative burden across healthcare delivery systems[4].
Aleen Inc. (CSE: ALEN-U), a Canadian technology company operating in the digital wellness space, has announced it is beginning early concept testing for smart wellness analytics, building on its previous initiative to enhance personalized interpretation of wellness information. The company is exploring how analytical tools could help users recognize trends and behavior patterns in their wellness data over time, while remaining entirely outside clinical or diagnostic functions.
“Our current focus is on understanding how an analytical tool can responsibly support everyday well-being — while staying entirely outside the realm of diagnostic or medical functions,” said Anastasiia Kalashnik, PR Specialist of Aleen Inc. “We are laying the groundwork for a feature that inspires awareness and self-reflection, not prescribes actions.”
Based in Ontario, Aleen Inc. went public on the Canadian Securities Exchange in June 2025 and has developed an AI platform designed to help users understand their inputs and wellness indicators. The current testing phase focuses on assessing real user needs and expectations, exploring potential analytical approaches that could simplify recognition of trends over time, and conducting scenario-based evaluations to understand how structured insights might enhance personal well-being awareness.
Aleen Inc. operates in a rapidly expanding market. The global digital wellness sector is currently valued at approximately $12.87 billion in 2025 and is projected to grow to $45.65 billion by 2034, representing annual growth of 15.1%. With about 57% of consumers now using digital apps and wearable devices to monitor their well-being, Aleen Inc. is positioned to capture a portion of this expanding demand.
The Aleen AI system can be accessed in two ways. Users can visit the Aleen website for free wellness insights, which helps raise awareness and encourages active engagement with personal well-being. Businesses can integrate Aleen Inc.’s technology via its API, allowing wellness apps and digital platforms to embed the AI-powered insights into their own services.
The company generates revenue through its API offerings, available through a per-call option for businesses paying only for requests used, and a monthly subscription for consistent access. Looking ahead to 2026, Aleen Inc. plans to launch personal user accounts that will allow individuals to securely store and organize their wellness information in one place, alongside introducing the smart analytics features currently in early testing.
To fund these initiatives, Aleen Inc. is currently seeking between $20 million and $30 million in strategic investment. The company plans to allocate 35% of these funds toward technology development, 30% toward sales and marketing efforts, and 20% for product expansion including mobile apps and specialized modules for corporate wellness programs.
The company emphasizes that its platform is designed for preliminary wellness insights only and is not intended to replace consultations with healthcare professionals. Aleen Inc. does not provide medical diagnoses and is not regulated as a medical device by the FDA or other health authorities.
With 12,643,300 common shares currently issued and outstanding, Aleen Inc. continues to build its presence in the digital wellness space under the leadership of CEO Inna Aksman.
CONTINUED… Read this and more news for Aleen Inc. at:
AI Engine Replaces The Waiting Room: Powering The $660B Health Revolution
Workday, Inc. (NASDAQ: WDAY) has successfully deployed its AI-powered enterprise platform across Advocate Health, the third-largest not-for-profit health care organization in the U.S., unifying HR, finance, and supply chain operations for 160,000 employees across more than 60 hospitals and 1,000 sites of care in six states. The implementation has centralized workforce, financial operations, and procurement data on a single intelligent platform designed to simplify employee tasks and improve patient care delivery.
“Health care organizations benefit from having a trusted partner to help them navigate the industry’s changing needs while digitally transforming the ways in which they operate,” said Dr. Bobbie Byrne, COO of Advocate Health. “For us, Workday is that partner. It provides the reliability, performance, and data quality we need as we continue to redefine health care for our patients and communities.”
With Workday HCM, Advocate Health has simplified employee task management through mobile access to scheduling and payroll functions, while Workday Financial Management provides real-time financial data visibility for faster decision-making. The deployment also includes Workday SCM for Healthcare with AI-powered automation that enables smarter inventory tracking, quicker expense processing, and intelligent tools like automatic receipt scanning to ensure vital resources reach caregivers when needed.
GE HealthCare Technologies (NASDAQ: GEHC) has announced collaborations with major medical systems including The Queen’s Health Systems in Honolulu and Duke Health in Durham to advance development of its new AI-driven hospital operations software that will use artificial intelligence and predictive analytics to recommend actions designed to help care teams improve quality of care, patient flow, and maximize resources. The forthcoming cloud-first Software as a Service solution will be part of GE HealthCare’s CareIntellect family of applications, drawing on insights from nearly 500 hospitals and medical facilities using Command Center across 55,000 beds globally.
“At Queen’s, we believe in the power of technology to empower clinicians and improve patient care,” said Ashley Shearer, Vice President, Care Coordination, Patient Flow, Geriatrics, and Inpatient Rehab at The Queen’s Medical Center. “As a current user of GE HealthCare’s Command Center software, we have seen firsthand how data-driven insights are helping us better advance our mission to deliver the best care in the best possible way. With the support of GE HealthCare’s technology and change management expertise, alongside other key initiatives, we have been able to improve access to care and increase the number of transfer patients by more than 22%.”
The new application will help hospital leaders address growing patient volumes and acuity, staff shortages, and rising costs by providing recommended actions and predictive analytics across bed demand, staffing, and equipment management. The Queen’s Health Systems has achieved measurable impact with Command Center, including a 22.2% jump in patient transfer admissions allowing 100 additional monthly transfer patients, a 41.2% decrease in emergency department length of stay, a 1.07-day overall decrease in patient length of stay, and an estimated $20 million in savings through reduced length of stay in the first year.
Johnson & Johnson MedTech (NYSE: JNJ) has announced advancements in robotics development with physical artificial intelligence technologies that create simulated environments to accelerate future product innovation, optimize clinical workflows, and improve training for clinical teams through collaboration with NVIDIA Corporation (NASDAQ: NVDA). The company is using AI-driven simulation in development of the MONARCH Platform for Urology, where virtual operating room environments can be created to assist clinical teams in setting up the robotic system before starting procedures, with simulated patient anatomy and clinical scenarios generated to model kidney stone procedures for learning and procedure planning.
“Simulation is the next frontier in surgical robotics,” said Neda Cvijetic, Senior Vice President, Global Head of Robotics & Digital R&D, MedTech, Johnson & Johnson. “With AI-driven simulation, we can create high-fidelity digital twins that adhere to the laws of physics, can simulate the real world, and ultimately unlocks physical AI capabilities. As we launch new robotics technologies and continue accelerating our innovation pipeline, these simulations have the potential to enhance our differentiated technology development in support of our mission to deliver better patient outcomes.”
Leveraging NVIDIA Isaac for Healthcare, Johnson & Johnson MedTech can create high-fidelity digital twins using NVIDIA Omniverse libraries and build applications that simulate how the system may perform in the operating room and inside a patient, with NVIDIA Cosmos world foundation models for synthetic data generation helping complete the picture with highly accurate, physics-based data.
The MONARCH Platform for Urology will be commercially available in the U.S. in 2026 as the latest innovation for robotic-assisted urologic procedures, with robotic assistance designed to allow surgeons to maintain precise instrument control during kidney stone procedures while providing the freedom to perform multiple tasks simultaneously by a single operator.
Article Sources: https://equity-insider.com/2025/10/31/ai-engine-replaces-the-waiting-room-powering-the-660b-health-revolution/
CONTACT:
USA NEWS GROUP
info@usanewsgroup.com
(604) 265-2873
DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Equity-Insider.com is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Aleen Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares Aleen Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Aleen Inc. which were purchased in the open market. MIQ reserves the right to buy and sell, and will buy and sell shares of Aleen Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. Aleen’s solutions operate within the wellness domain and are not subject to FDA or Health Canada approval.
—
SOURCES:
1. https://hitconsultant.net/2025/10/22/healthcare-ai-adoption-is-2-2x-faster-than-the-broader-economy/
2. https://www.precedenceresearch.com/wellness-apps-market
3. https://www.globenewswire.com/news-release/2025/10/21/3170253/0/en/Healthcare-Adopts-AI-2-2x-Faster-than-Other-Industries-Driving-Record-1-4B-in-AI-Spending.html
4. https://www.pharmiweb.com/press-release/2025-10-24/patient-engagement-solutions-market-research-size-share-growth-trends-and-forecast-to-2029
